| Bioactivity | Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative related diseases such as Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), or cardiovascular disease including atherosclerosis[1]. |
| Name | Lp-PLA2-IN-12 |
| CAS | 2637485-14-2 |
| Formula | C24H23F2N5O3 |
| Molar Mass | 467.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiao Qiong, et al. Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof. Patent, CN112574221A. |
Lp-PLA2-IN-12
CAS: 2637485-14-2 F: C24H23F2N5O3 W: 467.47
Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative relate
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.